These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 8859059)

  • 1. Screening for cognitive dysfunction in multiple sclerosis.
    Basso MR; Beason-Hazen S; Lynn J; Rammohan K; Bornstein RA
    Arch Neurol; 1996 Oct; 53(10):980-4. PubMed ID: 8859059
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A short version of Rao's Brief Repeatable Battery as a screening tool for cognitive impairment in multiple sclerosis.
    Portaccio E; Goretti B; Zipoli V; Siracusa G; Sorbi S; Amato MP
    Clin Neuropsychol; 2009 Feb; 23(2):268-75. PubMed ID: 18609336
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Three screening batteries to detect cognitive impairment in multiple sclerosis.
    Aupperle RL; Beatty WW; Shelton Fde N; Gontkovsky ST
    Mult Scler; 2002 Oct; 8(5):382-9. PubMed ID: 12356204
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identifying multiple sclerosis patients with mild or global cognitive impairment using the Screening Examination for Cognitive Impairment (SEFCI).
    Beatty WW; Paul RH; Wilbanks SL; Hames KA; Blanco CR; Goodkin DE
    Neurology; 1995 Apr; 45(4):718-23. PubMed ID: 7723961
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development and validation of a brief electronic screening test for cognitive impairment in multiple sclerosis (SCI-MS Test).
    Meca-Lallana JE; Prieto-González JM; Jimenez-Veiga J; Carreón-Guarnizo E; Jiménez-Martín I; Hernández-Clares R; Sistiaga-Berrondo A; Carles-Dies R; García-Molina E; Cerdán-Sánchez M; Costa-Arpín E; Croitoru I; Castillo-Triviño T; Iniesta-Martinez F; García-Pérez E; Olascoaga-Urtaza J
    Mult Scler Relat Disord; 2019 Feb; 28():50-56. PubMed ID: 30553169
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Screening for multiple sclerosis cognitive impairment using a self-administered 15-item questionnaire.
    Benedict RH; Munschauer F; Linn R; Miller C; Murphy E; Foley F; Jacobs L
    Mult Scler; 2003 Feb; 9(1):95-101. PubMed ID: 12617275
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A preliminary validation of the brief international cognitive assessment for multiple sclerosis (BICAMS) tool in an Irish population with multiple sclerosis (MS).
    O'Connell K; Langdon D; Tubridy N; Hutchinson M; McGuigan C
    Mult Scler Relat Disord; 2015 Nov; 4(6):521-5. PubMed ID: 26590658
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of the abbreviated minimal assessment of cognitive function in multiple sclerosis (aMACFIMS) and the brief international cognitive assessment for multiple sclerosis (BICAMS).
    Gromisch ES; Portnoy JG; Foley FW
    J Neurol Sci; 2018 May; 388():70-75. PubMed ID: 29627034
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuropsychological and MRI measures predict short-term evolution in benign multiple sclerosis.
    Portaccio E; Stromillo ML; Goretti B; Zipoli V; Siracusa G; Battaglini M; Giorgio A; Bartolozzi ML; Guidi L; Sorbi S; Federico A; Amato MP; De Stefano N
    Neurology; 2009 Aug; 73(7):498-503. PubMed ID: 19641173
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Screening for cognitive impairment in multiple sclerosis. An evaluation of the Mini-Mental State Examination.
    Beatty WW; Goodkin DE
    Arch Neurol; 1990 Mar; 47(3):297-301. PubMed ID: 2310313
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cognitive impairment and its relation with disease measures in mildly disabled patients with relapsing-remitting multiple sclerosis: baseline results from the Cognitive Impairment in Multiple Sclerosis (COGIMUS) study.
    Patti F; Amato MP; Trojano M; Bastianello S; Tola MR; Goretti B; Caniatti L; Di Monte E; Ferrazza P; Brescia Morra V; Lo Fermo S; Picconi O; Luccichenti G;
    Mult Scler; 2009 Jul; 15(7):779-88. PubMed ID: 19542262
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Symbol Digit Modalities Test as sentinel test for cognitive impairment in multiple sclerosis.
    Van Schependom J; D'hooghe MB; Cleynhens K; D'hooge M; Haelewyck MC; De Keyser J; Nagels G
    Eur J Neurol; 2014 Sep; 21(9):1219-25, e71-2. PubMed ID: 24850580
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Interest of a new instrument to assess cognition in schizophrenia: The Brief Assessment of Cognition in Schizophrenia (BACS)].
    Bralet MC; Navarre M; Eskenazi AM; Lucas-Ross M; Falissard B
    Encephale; 2008 Dec; 34(6):557-62. PubMed ID: 19081451
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A brief neuropsychological screening test battery for cognitive dysfunction in Brazilian multiple sclerosis patients.
    Negreiros MA; Mattos P; Landeira-Fernandez J; Paes RA; Alvarenga RP
    Brain Inj; 2008 May; 22(5):419-26. PubMed ID: 18415722
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The association between cognitive impairment and physical disability in multiple sclerosis.
    Lynch SG; Parmenter BA; Denney DR
    Mult Scler; 2005 Aug; 11(4):469-76. PubMed ID: 16042232
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cognitive Impairment in Multiple Sclerosis: A Review of Neuropsychological Assessments.
    Korakas N; Tsolaki M
    Cogn Behav Neurol; 2016 Jun; 29(2):55-67. PubMed ID: 27336803
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Brief International Cognitive Assessment for Multiple Sclerosis (BICAMS): Canadian contribution to the international validation project.
    Walker LA; Osman L; Berard JA; Rees LM; Freedman MS; MacLean H; Cousineau D
    J Neurol Sci; 2016 Mar; 362():147-52. PubMed ID: 26944137
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rapid cognitive screening in multiple sclerosis accomplished by the Free Recall and Recognition Test.
    Claesson IM; Ytterberg C; Johansson S; Almkvist O; von Koch L
    Mult Scler; 2007 Mar; 13(2):272-4. PubMed ID: 17439898
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Symbol Digit Modalities Test is an effective cognitive screen in pediatric onset multiple sclerosis (MS).
    Charvet LE; Beekman R; Amadiume N; Belman AL; Krupp LB
    J Neurol Sci; 2014 Jun; 341(1-2):79-84. PubMed ID: 24792098
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cognitive loss in multiple sclerosis. Case reports and review of the literature.
    Franklin GM; Nelson LM; Filley CM; Heaton RK
    Arch Neurol; 1989 Feb; 46(2):162-7. PubMed ID: 2644924
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.